Izotropic Corporation is a Canada-based medical device company. The Company is engaged in commercializing imaging-based products utilizing emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers. Its lzoView computed tomography (CT) Imaging System is intended to produce cross-sectional images of anatomy that can be imaged in the 30 cm aperture by computer reconstruction of x-ray transmission data for non-invasive visualization of tissue. The IzoView is for use in the non-invasive visualization of breast tissue, as an adjunct tool to mammography, by providing x-ray computer reconstructed images as an aid for qualified healthcare providers. The Company has not generated any revenue.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26-07-10	$0.2650	+1.92%	6,893
26-07-09	$0.2600	+6.12%	4,586
26-07-08	$0.2450	-5.77%	33,500
26-07-07	$0.2600	-8.77%	47,162

Delayed Quote Canadian Securities Exchange

More quotes

Income Statement and Estimates

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Delayed Canadian Securities Exchange Other stock markets 10:56:16 2026-07-10 EDT			5-day change	1st Jan Change
0.2650 ^CAD	0.00%		-7.02%	-5.36%

07-02	Izotropic Corporation and Izotropic Africa Executes Formal Agreement for Exclusive Commercialization and Distribution of IzoView in Africa and Gulf Cooperation Council	CI
04-29	Izotropic Corporation Launches Izotropic Africa Operations in Casablanca	CI

Market Cap	13.07M 11.46M 10.62M 9.77M 18.48M 1.25B 18.83M 127M 49.62M 614M 49.07M 48M 2.12B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	13.07M 11.46M 10.62M 9.77M 18.48M 1.25B 18.83M 127M 49.62M 614M 49.07M 48M 2.12B	EV / Sales 2026 *	2.61x	EV / Sales 2027 *	1.31x
Free-Float	91.99%	Yield 2026 *	-	Yield 2027 *	-

07-02	Izotropic Corporation and Izotropic Africa Executes Formal Agreement for Exclusive Commercialization and Distribution of IzoView in Africa and Gulf Cooperation Council	CI
04-29	Izotropic Corporation Launches Izotropic Africa Operations in Casablanca	CI
03-27	Izotropic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2026	CI
02-18	Izotropic Corporation And Business Group Enter Letter Agreement To Establish Izotropic Africa For Licensing, Marketing, Distribution, And Manufacturing Of IzoView Breast CT In Africa And GCC	CI
02-04	Izotropic Raises $300,000 Via a Non-Brokered Private Placement and Announces Debt Settlement	MT
02-03	Izotropic Corporation announced that it has received CAD 0.3 million in funding	CI
01-28	Izotropic to Raise $300,000 Via Non-Brokered Private Placement	MT
01-27	Izotropic Corporation announced that it expects to receive CAD 0.3 million in funding	CI
12-30	Izotropic Corporation Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2025	CI
25-10-23	Izotropic Corporation Develops the IzoView Breast CT Imaging System	CI
25-09-29	Izotropic Corporation Reports Earnings Results for the First Quarter Ended July 31, 2025	CI
25-09-23	Izotropic Launches Personalized Radiation Dose Feature For Breast CT Scans	MT
25-09-23	Izotropic's IzoView Breast CT the First in Category to Offer Patent-Pending Personalized Radiation Dose	CI

07-02	Izotropic Executes Formal Agreement with Izotropic Africa for Exclusive Distribution Throughout Africa and the GCC	NE
04-29	Izotropic Africa Launches Operations in Casablanca	NE
04-21	Izotropic Announces Debt Settlement	NE
02-25	Izotropic's "Izotropic Africa" Enters Partnership Discussions with the Mohammed VI Foundation for Science & Health	NE
02-18	Izotropic Signs Letter Agreement for Regional Operations in Africa & the GCC	NE

Izotropic Corporation Stock

Stocks

IZO

CA46604F1099

Advanced Medical Equipment & Technology

Valuation: Izotropic Corporation

Chart: Izotropic Corporation

Latest news : Izotropic Corporation

Press Releases: Izotropic Corporation

News in other languages: Izotropic Corporation

Quotes and Performance

Course Extremes

Managers and Directors: Izotropic Corporation

Latest insider transactions

Medical Imaging Systems

Financials

Company Profile

Quotes

Income Statement and Estimates

Quarterly revenue - Rate of surprise

25-05-20	FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update
25-05-20	FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update
24-01-31	Izotropic erhält Antwort von der US-Behörde FDA
24-01-31	Izotropic erhält Antwort von der US-Behörde FDA
24-01-10	Izotropic gibt Updates zu regulatorischen und betrieblichen Themen

1 week	-7.02%
Current month	+10.42%
1 month	+1.92%
3 months	+15.22%
6 months	-7.02%
Current year	-5.36%

1 week	0.24	0.28
1 month	0.23	0.3
Current year	0.19	0.33
1 year	0.19	0.49
3 years	0.04	0.49
5 years	0.04	1.24
10 years	0.04	1.56

Manager	Title	Age	Since
Robert Louis Thast CEO	Chief Executive Officer	73	2023-05-31
Ralph Proceviat DFI	Director of Finance/CFO	75	2022-12-31
Younes Achkire COO	Chief Operating Officer	-	2022-12-31

Director	Title	Age	Since
Robert Louis Thast BRD	Director/Board Member	73	2016-05-18
Ali Sodagar BRD	Director/Board Member	51	2017-05-21
John Boone BRD	Director/Board Member	71	2017-04-30

Date	Insider	Type	Main position	Quantity	% Market Cap.
25-09-17	Ralph Proceviat	Option	Chief Financial Officer	100,000	0.1761%
25-09-17	Ralph Proceviat	Option	Chief Financial Officer	100,000	0.1761%
25-09-16	Ralph Proceviat	Sell	Chief Financial Officer	100,000	0.1761%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IZOTROPIC CORPORATION	0.00%	-7.02%	+1.92%	-8.62%	13.07M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-0.56%	+3.30%	-13.63%	-23.51%	13.18B
IRAY GROUP	-8.01%	-18.84%	+53.00%	-3.96%	4.59B
IRADIMED CORPORATION	+0.24%	-4.76%	+67.78%	+110.39%	1.24B
SONOSCAPE MEDICAL CORP.	+0.58%	-2.56%	-33.90%	-61.77%	1.2B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-1.66%	-1.47%	-38.67%	-47.05%	1.13B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	0.00%	-5.30%	-47.13%	-	880M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	-8.91%	-12.13%	+128.43%	+118.88%	615M
CAPSOVISION, INC.	+4.42%	-5.45%	+43.02%	-	299M
FISCHER MEDICAL VENTURES LIMITED	-1.34%	-2.77%	-54.66%	+218.50%	263M
Average	-1.52%	-4.50%	+10.61%	+37.86%	2.34B
Weighted average by Cap.	-2.11%	-0.88%	+4.25%	-8.44%

	2026 *	2027 *
Net sales	5M 4.39M 4.06M 3.74M 7.07M 479M 7.21M 48.41M 18.99M 235M 18.78M 18.37M 812M	10M 8.77M 8.12M 7.47M 14.14M 957M 14.41M 96.82M 37.97M 470M 37.55M 36.73M 1.62B
Net income	2.69M 2.36M 2.19M 2.01M 3.81M 258M 3.88M 26.08M 10.23M 127M 10.12M 9.9M 437M	6.63M 5.81M 5.39M 4.95M 9.37M 634M 9.55M 64.18M 25.17M 312M 24.89M 24.35M 1.08B
Net Debt	-	-